Delivery Order SPE2DB20D7059-SPE2DB24FQMU2

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,299.60 firm fixed price delivery order is for the supply of Triamterene-HCTZ 37.5-25 mg tablets in 500-count packages. The contract has an ultimate completion date of September 20, 2024 and does not utilize any set-asides. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,839.00 Firm Fixed Price Delivery Order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG Tablets (500 count) with a completion date of May 3, 2024. The contract was awarded under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.35 firm fixed-price delivery order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a cardiovascular medication. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,454.28, is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG tablets in quantities of 500 per bottle. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 12, 2025. This award is not designated as a set-aside contract. AmerisourceBergen maintains a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of triamterene-HCTZ 75-50 mg tablets. The contract, valued at $1,167.96, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,398.80, is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $2,135.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a period of performance through December 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The federal contract award summarized is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG tablets, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a total ceiling value of $2,241.11 and is a Firm Fixed Price Delivery Order running through July 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,003.27, is a delivery order with a firm fixed price pricing type. It is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.30 firm fixed price delivery order contract is for the supply of Triamterene-HCTZ 37.5-25 mg capsules to support military healthcare programs. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQMU2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,013.56 firm fixed-price delivery order is for the supply of Triamterene-HCTZ 37.5-25 mg tablets in quantities of 500. The award has no set-aside designation and represents a task order under the DLA Troop Support Medical Indefinite Delivery Contract, which has a ceiling value of up to $999,999,999 through December 2025. This contract vehicle enables the DLA to efficiently procure a wide range of essential pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, as a leading pharmaceutical distributor, leverages its extensive supply chain to provide critical care medications and medical commodities to various federal agencies and healthcare programs.

Generated 1/3/25, 9:04 AM